Terms ending in 2042
Every in-force patent on Seegene, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,188,082 | Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,394,503 | Method for Predicting the Melting Temperature of Oligonucleotide In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,391,997 | Method For Determining The Presence Or Absence Of M. Tuberculosis, M. Bovis And M. Bovis BCG In A Sample In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,443,028 | Light Module In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,573,474 | Method for Providing Target Nucleic Acid Sequence Data Set of Target Nucleic Acid Molecule In force · High confidence | Seegene, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.